GSK (BUE:GSK) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BUE:GSK GSK PLC BUE:GSK
64 GF Score
Price ARS20,620.00
GF Value ARS16,868.61
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is GSK FFO?

FFO (Funds from operations) only applies to REITs.

BUE:GSK
64GF Score
GSK PLC BUE:GSK
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is GSK (BUE:GSK) Overvalued in 2026?

Based on GuruFocus' analysis, GSK stock appears to be overvalued. The current stock price of ARS20,620.00 is trading 22.2% above its estimated GF Value™ of ARS16,868.61. GuruFocus considers GSK to be Modestly Overvalued.

Key valuation signals for BUE:GSK:

  • FFO:
  • GF Value™: ARS16,868.61 vs. price of ARS20,620.00 (22.2% above fair value)
  • GF Score™: 64/100 with 1 warning sign

No single metric tells the full story. See the BUE:GSK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


GSK Business Description

Address 79 New Oxford Street, London, GBR, WC1A 1DG
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
64GF Score

Get the complete analysis for BUE:GSK

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS20,620.00
Price
ARS16,868.61
GF Value